Simplex Trading’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,288
Closed -$898K 8471
2024
Q4
$865K Buy
6,288
+4,354
+225% +$572K ﹤0.01% 2989
2024
Q3
$288K Buy
+1,934
New +$261K ﹤0.01% 4170
2024
Q1
Sell
-2,270
Closed -$324K 8807
2023
Q4
$285K Buy
+2,270
New +$226K ﹤0.01% 4278
2023
Q3
Sell
-5,364
Closed -$502K 8613
2023
Q2
$478K Buy
+5,364
New +$467K ﹤0.01% 3363
2023
Q1
Sell
-1,617
Closed -$185K 8960
2022
Q4
$197K Buy
+1,617
New +$188K ﹤0.01% 4246
2021
Q4
Sell
-432
Closed -$64.3K 10424
2021
Q3
$58K Hold
432
﹤0.01% 7331
2021
Q2
$56K Sell
432
-1,562
-78% -$208K ﹤0.01% 7499
2021
Q1
$256K Sell
1,994
-2,264
-53% -$344K ﹤0.01% 4351
2020
Q4
$710K Buy
4,258
+3,095
+266% +$512K ﹤0.01% 2984
2020
Q3
$179K Sell
1,163
-844
-42% -$121K ﹤0.01% 4247
2020
Q2
$296K Sell
2,007
-5,927
-75% -$814K ﹤0.01% 3542
2020
Q1
$893K Buy
+7,934
New +$1.03M ﹤0.01% 1992
2019
Q4
Sell
-5,284
Closed -$587K 7255
2019
Q3
$508K Buy
5,284
+551
+12% +$61.5K ﹤0.01% 2606
2019
Q2
$545K Buy
+4,733
New +$566K ﹤0.01% 2478
2019
Q1
Sell
-14,993
Closed -$1.31M 7094
2018
Q4
$939K Buy
+14,993
New +$942K ﹤0.01% 1688
2018
Q3
Sell
-2,864
Closed -$197K 7366
2018
Q2
$190K Buy
+2,864
New +$188K ﹤0.01% 3539

Other funds holding ASND

Simplex Trading's ASND Position: Q1 2025 in Review

Simplex Trading sold out of Ascendis Pharma A/S (ASND) in Q1 2025, closing a stake of 6,288 shares — an estimated $898K sold.

Simplex Trading first reported a position in ASND in Q2 2018 and held it in 16 quarters. The position peaked at $939K in Q4 2018. 244 funds tracked by Wall St. Rank hold ASND as of Q1 2025.

  • Simplex Trading reported no remaining Ascendis Pharma A/S position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 6,288 Ascendis Pharma A/S shares in Q1 2025, an estimated $898K.
  • Simplex Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and held it in 16 quarters.
  • Simplex Trading's Ascendis Pharma A/S position peaked at $939K in Q4 2018.
  • 244 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.